Stock Analysis
Nucleus Software Exports Full Year 2024 Earnings: EPS Beats Expectations
Nucleus Software Exports (NSE:NUCLEUS) Full Year 2024 Results
Key Financial Results
- Revenue: ₹8.26b (up 30% from FY 2023).
- Net income: ₹1.92b (up 50% from FY 2023).
- Profit margin: 23% (up from 20% in FY 2023). The increase in margin was driven by higher revenue.
- EPS: ₹71.56 (up from ₹47.73 in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Nucleus Software Exports EPS Beats Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 4.0%.
The primary driver behind last 12 months revenue was the Products segment contributing a total revenue of ₹7.11b (86% of total revenue). Notably, cost of sales worth ₹4.96b amounted to 60% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to ₹1.08b (77% of total expenses). Explore how NUCLEUS's revenue and expenses shape its earnings.
Looking ahead, revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 14% growth forecast for the Software industry in India.
Performance of the Indian Software industry.
The company's shares are up 3.2% from a week ago.
Risk Analysis
Be aware that Nucleus Software Exports is showing 1 warning sign in our investment analysis that you should know about...
Valuation is complex, but we're helping make it simple.
Find out whether Nucleus Software Exports is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're helping make it simple.
Find out whether Nucleus Software Exports is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NSEI:NUCLEUS
Nucleus Software Exports
Provides lending and transaction banking products to the financial services industry in India, the Far East, South East Asia, Europe, the Middle East, Africa, Australia, and internationally.
Outstanding track record with flawless balance sheet and pays a dividend.